LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling-Reference-Cited by-同舟云学术

LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling

Published:2016-08-31 Issue:39 Volume:7 Page:63981-63994
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gao Yuan¹,Huang Yujie¹,Zhao Yue¹,Hu Yang¹,Li Zhiyu²,Guo Qinglong¹,Zhao Kai¹,Lu Na¹

Affiliation:

1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China

2. School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flavonoid derivatives treat dextran sodium sulfate-induced experimental colitis in mice by inhibiting MAPK/NF-κB pathway activation;European Journal of Medicinal Chemistry Reports;2024-12

2. Walnut Protein Peptides Ameliorate DSS-Induced Ulcerative Colitis Damage in Mice: An in Silico Analysis and in Vivo Investigation;Journal of Agricultural and Food Chemistry;2023-10-10

3. Icosapent ethyl alleviates acetic acid-induced ulcerative colitis via modulation of SIRT1 signaling pathway in rats;International Immunopharmacology;2023-02

4. Pharmacology Mechanism of Polygonum Bistorta in Treating Ulcerative Colitis Based on Network Pharmacology;Evidence-Based Complementary and Alternative Medicine;2022-12-28

5. Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease;Pharmacological Reports;2021-01-19